Company / Income Tax per Share
ENANTA PHARMACEUTICALS INC Income Tax per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$0.13
FY2025
5-year range
-$1.37 / $0.13
FY2021-FY2025
Trend
+747.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Income Tax per Share changed +747% YoY in FY2025, a notable deviation from the 9-year average annual change of -123%.
Based on SEC 10-K filings.
0.13 in FY2025 with a 5-year CAGR of -34.1%.
Increased from $-1.37 to $0.13 over the past 2 years.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- +32.8%
- 5-Year CAGR
- -34.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, income tax per share increased 747.4% year-over-year.
- Peak income tax per share was recorded in FY2017.
- Lowest income tax per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.13 | +747.4% |
| FY2024 | -$0.02 | +98.5% |
| FY2023 | -$1.37 | -2521.5% |
| FY2022 | $0.06 | +238.0% |
| FY2021 | -$0.04 | -103.8% |
| FY2020 | $1.07 | +125.6% |
| FY2019 | $0.48 | -16.4% |
| FY2018 | $0.57 | -76.7% |
| FY2017 | $2.44 | +401.1% |
| FY2016 | -$0.81 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026